Phase III trial of Sci-B-Vac
Phase of Trial: Phase III
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary)
- Indications Hepatitis B
- Focus Registrational; Therapeutic Use
- Acronyms CONSTANT
- 13 Jul 2017 New trial record
- 11 Jul 2017 According to a VBI Vaccinesmedia release, the company had a positive discussions with the U.S. Food & Drug Administration (FDA), the European Medicines Agency (EMA), and Health Canada for the conduct of this study.
- 11 Jul 2017 According to a VBI Vaccinesmedia release, the initiating enrollment in this study in the second half of 2017.